Skip to main content
. 2014 Oct 15;7(11):7378–7388.

Figure 2.

Figure 2

AMPK and eNOS were involved in protection of HPC against H/R injury in H9c2 cells. CCK-8 cell viability assay showing H9c2 cells proliferation. HPC increased the cells proliferation against H/R injury, which was abolished by AMPK inhibitor Compound C and eNOS inhibitor L-NIO, and mimicked by AMPK activator metformin in part. *P < 0.05 vs. Control; #P < 0.05 vs. H/R; &P < 0.05 vs. HPC.